The importance of tight glycemic control

American Journal of Medicine

Volumn 118, Issue 9 SUPPL., 2005, Pages 7-11

  Gerich, John E ^a,b  

^a UNIVERSITY OF ROCHESTER   (United States)

^b UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

Author keywords

Hypoglycemia; Macrovascular; Postprandial; Self monitoring of blood glucose

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; GLUCOSE; HEMOGLOBIN A1C; INSULIN DERIVATIVE; METFORMIN;

ATHEROGENESIS; BLOOD GLUCOSE MONITORING; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; COST EFFECTIVENESS ANALYSIS; DIABETIC ANGIOPATHY; DIET RESTRICTION; DISEASE ASSOCIATION; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE; HEALTH CARE ORGANIZATION; HEMOGLOBIN DETERMINATION; HUMAN; HYPERGLYCEMIA; HYPOGLYCEMIA; IMPAIRED GLUCOSE TOLERANCE; INSULIN DEPENDENT DIABETES MELLITUS; LIFESTYLE; MICROANGIOPATHY; NON INSULIN DEPENDENT DIABETES MELLITUS; POSTPRANDIAL STATE; PRACTICE GUIDELINE; PRIORITY JOURNAL; QUALITY OF LIFE; REVIEW; RISK ASSESSMENT; RISK REDUCTION; SELF MONITORING; TREATMENT PLANNING; WEIGHT GAIN;

EID: 26844463066     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjmed.2005.07.051     Document Type: Article

References (63)

1. M. Laakso, S. Lehto Epidemiology of macrovascular disease in diabetes Diabetes Review 5 1997 294 315
2. J. Stamler, O. Vaccaro, J.D. Neaton, D. Wentworth Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial Diabetes Care 16 1993 434 444
3. W.B. Kannel, D.L. McGee Diabetes and cardiovascular disease the Framingham study JAMA 241 1979 2035 2038
4. R.S. Most, P. Sinnock The epidemiology of lower extremity amputations in diabetic individuals Diabetes Care 6 1983 87 91
5. O.I. Siitonen, L.K. Niskanen, M. Laakso, J.T. Siitonen, K. Pyorala Lower-extremity amputations in diabetic and nondiabetic patients a population-based study in eastern Finland Diabetes Care 16 1993 16 20
6. The Diabetes Control and Complications Trial Research Group Effect of intensive diabetes management on macrovascular events and risk factors in the Diabetes Control and Complications Trial Am J Cardiol 75 1995 894 903
7. The Writing Team for the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group Effect of intensive therapy on the microvascular complications of type 1 diabetes mellitus JAMA 287 2002 2563 2569
8. The Diabetes Control and Complications Trial Research Group The absence of a glycemic threshold for the development of long-term complications the perspective of the Diabetes Control and Complications Trial Diabetes 45 1996 1289 1298
9. 1c) to the risk of development and progression of retinopathy in the diabetes control and complications trial Diabetes 44 1995 968 983
10. Writing Team for the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group Sustained effect of intensive treatment of type 1 diabetes mellitus on development and progression of diabetic nephropathy the Epidemiology of Diabetes Interventions and Complications (EDIC) study JAMA 290 2003 2159 2167
11. UK Prospective Diabetes Study Group Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes UKPDS 38 BMJ 317 1998 703 713
12. UK Prospective Diabetes Study Group Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33) Lancet 352 1998 837 853
13. M. Shichiri, H. Kishikawa, Y. Ohkubo, N. Wake Long-term results of the Kumamoto Study on optimal diabetes control in type 2 diabetic patients Diabetes Care 23 suppl 2 2000 B21 B29
14. Y. Ohkubo, H. Kishikawa, E. Araki Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus a randomized prospective 6-year study Diabetes Res Clin Pract 28 1995 103 117
15. I.M. Stratton, A.I. Adler, H.A.W. Neil UK Prospective Diabetes Study Group Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35) prospective observational study BMJ 321 2000 405 412
16. K. Malmberg DIGAMI (Diabetes Mellitus Insulin Glucose Infusion in Acute Myocardial Infarction) Study Group Prospective randomised study of intensive insulin treatment on long term survival after acute myocardial infarction in patients with diabetes mellitus BMJ 314 1997 1512 1515
17. R.C. Eastman, J.C. Javitt, W.H. Herman Model of complications of NIDDM. II. Analysis of the health benefits and cost-effectiveness of treating NIDDM with the goal of normoglycemia Diabetes Care 20 1997 735 744
18. M.A. Testa, D.C. Simonson Health economic benefits and quality of life during improved glycemic control in patients with type 2 diabetes mellitus a randomized, controlled, double-blind trial JAMA 280 1998 1490 1496
19. G.L. King, H. Wakasaki Theoretical mechanisms by which hyperglycemia and insulin resistance could cause cardiovascular diseases in diabetes Diabetes Care 22 1999 C31 C37
20. H.E. Lebovitz Effect of the postprandial state on nontraditional risk factors Am J Cardiol 88 2001 20H 25H
21. D. Einhorn, M. Rendell, J. Rosenzweig Pioglitazone 027 Study Group Pioglitazone hydrochloride in combination with metformin in the treatment of type 2 diabetes mellitus a randomized, placebo-controlled study Clin Ther 22 2000 1395 1409
22. R. Marfella, L. Quagliaro, F. Nappo, A. Ceriello, D. Giugliano Acute hyperglycemia induces an oxidative stress in healthy subjects J Clin Invest 108 2001 635 636
23. S.B. Williams, A.B. Goldfine, F.K. Timimi Acute hyperglycemia attenuates endothelium-dependent vasodilation in humans in vivo Circulation 97 1998 1695 1701
24. L.M. Title, P.M. Cummings, K. Giddens, B.A. Nassar Oral glucose loading acutely attenuates endothelium-dependent vasodilation in healthy adults without diabetes an effect prevented by vitamins C and E J Am Coll Cardiol 36 2000 2185 2191
25. J.A. Beckman, A.B. Goldfine, M.B. Gordon, M.A. Creager Ascorbate restores endothelium-dependent vasodilation impaired by acute hyperglycemia in humans Circulation 103 2001 1618 1623
26. M. Meier, G.L. King Protein kinase C activation and its pharmacological inhibition in vascular disease Vasc Med 5 2000 173 185
27. G.H. Tomkin Diabetic vascular disease and the rising star of protein kinase C [editorial] Diabetologia 44 2001 657 658
28. B. Lipinski Pathophysiology of oxidative stress in diabetes mellitus J Diabetes Complications 15 2001 203 210
29. S.I. Yamagishi, D. Edelstein, X.L. Du, M. Brownlee Hyperglycemia potentiates collagen-induced platelet activation through mitochondrial superoxide overproduction Diabetes 50 2001 1491 1494
30. E. Selvin, S. Marinopoulos, G. Berkenblit Meta-analysis glycosylated hemoglobin and cardiovascular disease in diabetes mellitus Ann Intern Med 141 2004 421 431
31. M. Coutinho, H.C. Gerstein, Y. Wang, S. Yusuf The relationship between glucose and incident cardiovascular events a metaregression analysis of published data from 20 studies of 95,783 individuals followed for 12.4 years Diabetes Care 22 1999 233 240
32. 1c with cardiovascular disease and mortality in adults the European Prospective Investigation into Cancer in Norfolk Ann Intern Med 141 2004 413 420
33. K-T. Khaw, N. Wareham, R. Luben Glycated haemoglobin, diabetes, and mortality in men in Norfolk cohort of European Prospective Investigation of Cancer and Nutrition (EPIC-Norfolk) BMJ 322 2001 15 18
34. R.B. Goldberg, M.J. Mellies, F.M. Sacks CARE Investigators Cardiovascular events and their reduction with pravastatin in diabetic and glucose-intolerant myocardial infarction survivors with average cholesterol levels subgroup analyses in the Cholesterol and Recurrent Events (CARE) trial Circulation 98 1998 2513 2519
35. H.C. Gerstein Glycosylated hemoglobin finally ready for prime time as a cardiovascular risk factor [editorial] Ann Intern Med 141 2004 475 476
36. E. Renard Monitoring glycemic control the importance of self-monitoring of blood glucose Am J. Med 118 suppl 9A 2005 12S 19S
37. American Diabetes Association Summary of revisions for the 2005 clinical practice recommendations Diabetes Care 28 2005 S3
38. Canadian Diabetes Association Clinical Practice Guidelines Expert Committee Targets for glycemic control Canadian Journal of Diabetes 27 2003 S18 S20
39. American Association of Clinical Endocrinologists and American College of Endocrinology Implementation conference for ACE outpatient diabetes mellitus consensus conference recommendations position statement 2005 Available at: http://www.aace.com/pub/odimplementation/index.php. Accessed May 25
40. R. Corbin, J. Davidson, O. Ganda American College of Endocrinology consensus statement on guidelines for glycemic control Endocr Pract 8 2002 5 11
41. Agence Nationale d'Accreditation et d'Evaluation en Sante (ANAES) [French National Agency for Accreditation and Evaluation in Healthcare] Follow-up of the type 2 diabetic patient excluding follow-up of complications. recommendations of ANAES [in French] Diabetes Metab 25 suppl 2 1999 1 64
42. M.B. Davidson, D.L. Schriger, A.L. Peters, B. Lorber Relationship between fasting plasma glucose and glycosylated hemoglobin potential for false-positive diagnoses of type 2 diabetes using new diagnostic criteria JAMA 281 1999 1203 1210
43. 1c in the Diabetes Control and Complications Trial Diabetes Care 25 2002 275 278
44. 1c Diabetes Care 26 2003 881 885
45. 1c values Arch Intern Med 164 2004 1627 1632
46. J.E. Gerich Clinical significance, pathogenesis, and management of postprandial hyperglycemia Arch Intern Med 163 2003 1306 1316
47. D. Bruttomesso, A. Pianta, A. Mari Restoration of early rise in plasma insulin levels improves the glucose tolerance of type 2 diabetic patients Diabetes 48 1999 99 105
48. S.H. Saydah, C.M. Loria, M.S. Eberhardt, F.L. Brancati Subclinical states of glucose intolerance and risk of death in the US Diabetes Care 24 2001 447 453
49. J-L. Chiasson, R.G. Josse, R. Gomis, M. Hanefeld, A. Karasik, M. Laakso Acarbose treatment and the risk of cardiovascular disease and hypertension in patients with impaired glucose tolerance the STOP-NIDDM trial JAMA 290 2003 486 494
50. M. Hanefeld, M. Cagatay, T. Petrowitsch, D. Neuser, D. Petzinna, M. Rupp Acarbose reduces the risk for myocardial infarction in type 2 diabetic patients meta-analysis of seven long-term studies Eur Heart J 25 2004 10 16
51. R.J. Stevens, R.L. Coleman, A.I. Adler, I.M. Stratton, D.R. Matthews, R.R. Holman Risk factors for myocardial infarction case fatality and stroke case fatality in type 2 diabetes UKPDS 66 Diabetes Care 27 2004 201 207
52. The Diabetes Control and Complications Trial Research Group The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus N Engl J Med 329 1993 977 986
53. J.E. Gerich Hypoglycaemia and counterregulation in type 2 diabetes Lancet 356 2000 1946 1947
54. M.C. Riddle, J. Rosenstock, J. Gerich Insulin Glargine 4002 Study Investigators The Treat-to-Target Trial randomized addition of glargine or human NPH insulin to oral therapy of type 2 diabetic patients Diabetes Care 26 2003 3080 3086
55. C. Abraira, J.A. Colwell, F.Q. Nuttall Veterans Affairs Cooperative Study in Type II Diabetes Veterans Affairs Cooperative Study on glycemic control and complications in type II diabetes (VA CSDM) results of the feasibility trial Diabetes Care 18 1995 1113 1123
56. A. Gray, M. Raikou, A. McGuire United Kingdom Prospective Diabetes Study Group Cost effectiveness of an intensive blood glucose control policy in patients with type 2 diabetes economic analysis alongside randomised controlled trial (UKPDS 41) BMJ 320 2000 1373 1378
57. CDC Diabetes Cost-effectiveness Group Cost-effectiveness of intensive glycemic control, intensified hypertension control, and serum cholesterol level reduction for type 2 diabetes JAMA 287 2002 2542 2551
58. S.H. Saydah, J. Fradkin, C.C. Cowie Poor control of risk factors for vascular disease among adults with previously diagnosed diabetes JAMA 291 2004 335 342
59. C.E. Koro, S.J. Bowlin, N. Bourgeois, D.O. Fedder Glycemic control from 1988 to 2000 among US adults diagnosed with type 2 diabetes a preliminary report Diabetes Care 27 2004 17 20
60. J.B. Brown, G.A. Nichols, A. Perry The burden of treatment failure in type 2 diabetes Diabetes Care 27 2004 1535 1540
61. A.J. Garber Strategies for better diabetes control in the US Drugs 58 1999 61 69
62. J.E. Gerich The genetic basis of type 2 diabetes mellitus impaired insulin secretion versus impaired insulin sensitivity Endocr Rev 19 1998 491 503
63. S. Inzucchi Oral antihyperglycemic therapy for type 2 diabetes scientific review JAMA 287 2002 360 372